Camptocormia: As the First Sign of Parkinson's Disease
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BRIEF COMMUNICATIONS
and EMG on the thoracolumbar paraspinal muscles. Diffuse osteopenia was found on the plain lumbar spine series. Magnetic resonance imaging of the brain showed mild multifocal subcortical deep white matter hyperintensity and the positron emission tomography using 18 F-N-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane (FP-CIT) showed bilateral decreased striatal dopamine binding uptake compared with age-matched healthy control subject ( Figure 1 ). Myocardial 123 I-metaiodibenzylguanidine (MIBG) scintigraphy, six months after treatment, showed severe postganglionic sympathetic denervation ( Figure 2 )
The patient was treated initially with levodopa/carbidopa/ entacarpone 50/12.5/200 mg twice daily and pramipexole 0.25 mg twice daily, with marked improvement of the bradykinesia and rigidity. The levodopa dose was slowly increased to 150 mg three times a day over three months, and the patient noted significant improvement of the camptocormia (see the supplementary video online at www.cjns.org). The Hoehn & Yahr and UPDRS total, was 1 and 14 for the on-period.
Discussion
Initially, most patients with PD complain of the classic motor triad of symptoms: a resting tremor, bradykinesia and cogwheel rigidity. In addition, a mild stooped posture is a hallmark of Parkinsonism; extreme trunk forward flexion is not common. In very few cases, camptocormia occurs early; more frequently it is a manifestation of advanced disease 4 . A recent clinical study suggested that camptocormia was more common in patients with more severe PD, on longer levodopa treatment duration, with greater levodopa daily doses, and with dementia 2 . However, some have described conflicting results 5 . The pathophysiology of this condition is not clear, although two provisional mechanisms have been proposed; a central disorder or an outcome of peripheral mechanism 6 . Since some patients respond to dopaminergic therapy, it may be due to a dopamine deficiency observed with extrapyramidal 1, 7, 8 . However, the benefits of levodopa are very limited; many patients do not have obvious benefits, and levodopa worsened the condition in some patients suggesting additional, non-dopaminergic neuronal dysfunction in the basal ganglia 4, 9 . It should be ruled out the probability of atypical parkinsonisms with axial dystonia, because the clinical course in this patient was very rapid. However, the clear evidence of functional neuroimaging and the excellent response to levodopa were suggestive of idiopathic PD. Therefore, we think this case is the first to show camptocormia as the initial sign of PD.
